eir

 

Sun Pharma shares gain 4%; m-cap rises by Rs 2,384 cr

Jun 13 2018

Shares of Sun Pharmaceutical Industries today gained nearly 4 per cent after the company received EIR from the US health regulator for its Halol facility in Gujarat.

Suven Life shares gain 4.5% as its facility completes USFDA inspection

May 07 2018

Shares of Suven Life Sciences rose by 4.5% after the company said its Pashamylaram facility near Hyderabad has undergone successful inspection by the US health regulator.

FDA issues Establishment Inspection Report to Suven Life Sciences

May 07 2018

Suven Life Sciences Limited said the USFDA, which audited its facility near here, has closed the inspection 'no action Indicated (NAI) and issued an Establishment Inspection Report (EIR).

Hurricane Ophelia: Red wind warning extended across Ireland

Oct 16 2017

The Irish national meteorological service, Met Eireann, has upgraded the entire country to a status red wind alert over Hurricane Ophelia.

Dr Reddy's Laboratories shares jump nearly 5 percent

Sep 28 2017

Shares of Dr Reddy's Laboratories surged nearly 5 per cent after the company said it has received an EIR from the US health regulator for a unit.

USFDA makes 6 observations at Natco Pharma's Kothur facility

Jan 25 2017

Natco Pharma said the US health regulator has made six observations.

Indian Markets

 
  • SENSEX

    35,479.53 192.79   (0.55 %)
  • NIFTY

    10,762.00 51.55   (0.48 %)
sensex-box-shadowimg

Global Markets

 

Stocks In News

 

ICICI BANK

Minority investors divided over changes at ICICI bank

Fund managers seek clarity on governance & leadership for investment decisions

Kochhar's fully paid leave raises questions

Proxy advisory firm raises questions on remuneration

Mint Report

IIFL

Will issue 5.1% equity shares worth Rs 746 Cr to investors, priced at Rs 1,661/sh

IIFL's wealth management business valued at Rs 14,600 Cr

Investors include Amansa holdings, General Atlantic Singapore & HDFC Standard Life

CIPLA

Gets final USFDA approval for Generic Sustiva

U.S. Sales stood at approximately $105 Mn in a 12 month period, ending in April 2018

KANSAI NEROLAC

Nerolac to enter share purchase agreement with RAK paints in Bangladesh

Will acquire 55% paid up equity share capital in RAK paints for Rs 45.8 Cr

Acquisition to be complete by 31st July 2018

UPL

UPL consortium said to be in talks to buy platform's agri pesticide unit Arysta Lifescience

UPL to team up with Abu Dhabi investment authority for Arysta Lifescience

UPL group's talks for Arysta Lifescience unit said to be in advanced stages

twitter @BTVI